Kidney Transplantion Epstein Barr Virus clinical trials

Explore recruiting kidney transplantion epstein barr virus clinical trials.

Also recruiting in Europe

Kidney Transplantion Epstein Barr Virus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicenter randomized two arms study evaluating the efficacy of prophylactic Rituximab in EBV negative kidney transplant recipients on incidence of EBV primary infection and post-transplant lymphoproliferative disorders - REPLY

France

Therapeutic use (Phase IV) EU CTIS Study details

Kidney Transplantion Epstein Barr Virus trials by city

Kidney Transplantion Epstein Barr Virus in Toronto Kidney Transplantion Epstein Barr Virus in Vancouver Kidney Transplantion Epstein Barr Virus in Montreal Kidney Transplantion Epstein Barr Virus in Calgary Kidney Transplantion Epstein Barr Virus in Edmonton Kidney Transplantion Epstein Barr Virus in Ottawa Kidney Transplantion Epstein Barr Virus in Winnipeg Kidney Transplantion Epstein Barr Virus in Quebec City Kidney Transplantion Epstein Barr Virus in Hamilton Kidney Transplantion Epstein Barr Virus in Kitchener Kidney Transplantion Epstein Barr Virus in London Kidney Transplantion Epstein Barr Virus in Halifax Kidney Transplantion Epstein Barr Virus in New York Kidney Transplantion Epstein Barr Virus in Los Angeles Kidney Transplantion Epstein Barr Virus in Chicago Kidney Transplantion Epstein Barr Virus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease